Zenalpha
medetomidine hydrochloride / vatinoxan hydrochloride
Table of contents
Overview
Zenalpha is a medicine used to sedate (calm down) dogs during non-invasive, non-painful or mildly painful veterinary procedures lasting less than 30 minutes that require the animal to be restrained or sedated and made less sensitive to pain.
Zenalpha contains the active substances medetomidine and vatinoxan.
Authorisation details
Product details | |
---|---|
Name |
Zenalpha
|
Agency product number |
EMEA/V/C/005465
|
Active substance |
|
International non-proprietary name (INN) or common name |
|
Species |
Dogs
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QN05CM99
|
Publication details | |
---|---|
Marketing-authorisation holder |
Vetcare Oy
|
Date of issue of marketing authorisation valid throughout the European Union |
15/12/2021
|
Contact address |
P.O.Box 99 |
Product information
Zenalpha - EMEA/V/C/005465 -
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Psycholeptics, hypnotics and sedatives
Therapeutic indication
To provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.